☆ 4.7 Article

Boosting regulatory T cell-dependent immune tolerance by activation of p53

INTERNATIONAL IMMUNOPHARMACOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cell Biology

Regulation of immunological tolerance by the p53-inhibitor iASPP

Elliot H. H. Akama-Garren et al.

Summary: Maintaining a balance between tolerance and autoimmunity is crucial for preventing human diseases. The protein p53 and its regulator iASPP play important roles in immunological tolerance and tumorigenesis. Deficiency in iASPP promotes tumor development but reduces susceptibility to autoimmune diseases. Furthermore, iASPP-deficient tumors exhibit immunosuppression characteristics, suggesting potential therapeutic opportunities for targeting the iASPP/p53 axis in autoimmune diseases and cancer.

CELL DEATH & DISEASE (2023)

添加到收藏夹

Article Dermatology

Novel RNA polymerase I inhibitor CX-5461 suppresses imiquimod-induced experimental psoriasis

Xiao Wu et al.

Summary: CX-5461, a selective inhibitor of RNA polymerase I, demonstrates therapeutic effects on experimental psoriasis in mice, possibly through multiple mechanisms including anti-proliferative, anti-inflammatory, and anti-angiogenic activities.

EXPERIMENTAL DERMATOLOGY (2023)

添加到收藏夹

Review Immunology

An Immune Atlas of T Cells in Transplant Rejection: Pathways and Therapeutic Opportunities

Sarah Short et al.

Summary: Short-term outcomes in allotransplantation have improved, but long-term outcomes remain a challenge. Acute cellular rejection, mediated by different types of T cells, plays a crucial role in the development of graft dysfunction and loss. Regulatory T cell subsets have the potential to promote allograft tolerance and understanding their contributions could lead to new therapeutic interventions.

TRANSPLANTATION (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

CX-5461 is a potent immunosuppressant which inhibits T cell-mediated alloimmunity via p53-DUSP5

Guopin Pan et al.

Summary: CX-5461, a selective inhibitor of RNA polymerase I, exhibits anti-inflammatory activities. This study demonstrates that CX-5461 has potential immunosuppressive effects by preventing acute allograft rejections through expansion of regulatory T cell population and inhibition of T cell activation. The immunosuppressive mechanism involves the p53-DUSP5 axis and antagonism of the Erk1/2 pathway.

PHARMACOLOGICAL RESEARCH (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

A transcriptional program associated with cell cycle regulation predominates in the anti-inflammatory effects of CX-5461 in macrophage

Jie Wang et al.

Summary: The study found that CX-5461 primarily induced cell cycle inhibition in activated macrophages, without inducing a systemic anti-inflammatory transcriptional program, although some inflammatory genes were downregulated by CX-5461.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Review Immunology

The expanding impact of T-regs in the skin

Edries Yousaf Hajam et al.

Summary: As the interface between the body and the environment, the skin not only acts as a physical barrier, but also as an immunologically active organ. Regulatory T cells (T-regs) play a crucial role in maintaining homeostasis, clearing pathogens, and promoting wound healing. Recent studies have uncovered non-lymphoid functions of cutaneous T-regs, suggesting that they have executive control over various biological activities in the skin. These findings highlight the importance of T-regs and their potential role in future discoveries in the field of regenerative medicine.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management

Nicole A. Pilch et al.

Summary: The evolution of immunosuppression regimens in solid organ transplants in the United States over the past 70 years has been marked by significant advancements but also ongoing challenges in achieving the optimal balance between under- and overimmunosuppression. The development of effective regimens has been limited by factors such as the limited number of agents, early stages of HLA matching techniques, and lack of understanding of immunoreactivity. Future directions in transplant immunosuppression aim to move towards patient-specific optimization for optimal long-term outcomes.

PHARMACOTHERAPY (2021)

添加到收藏夹

Review Immunology

Regulatory T Cell Heterogeneity in the Thymus: Impact on Their Functional Activities

Jeremy C. Santamaria et al.

Summary: Foxp3(+) regulatory T cells maintain organism integrity by preventing excessive immune responses, protecting against autoimmune diseases, and regulating other immune responses including inflammation, allergy, infection, and tumors. They also have non-immune functions such as tissue repair and regeneration. In the thymus, Foxp3(+) Treg develop with distinct precursors and exhibit diverse regulatory activities. Additionally, thymic Treg cell pool contains both newly developing Treg and recirculating peripheral cells, impacting Treg activity in the periphery.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Immunology

Regulatory T cells and transplantation tolerance: Emerging from the darkness?

Herman Waldmann

Summary: The field of tissue transplantation is moving towards harnessing physiological mechanisms of self-tolerance, with the recent discovery of Treg playing a crucial role. Despite limited knowledge on how Treg function in averting transplant rejection, therapeutic needs are driving the utilization of Treg as agents to potentially replace or complement current drug combinations.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Regulatory T Cells and Diabetes Mellitus

Weidong Qin et al.

Summary: Immune system dysfunction can lead to autoimmune diseases, with regulatory T cells (Tregs) playing a crucial role in the development of diabetes mellitus (DM) and its complications, including cardiovascular diseases, nephropathy, neuropathy, and retinopathy. Modifying Tregs may offer a promising strategy for the prevention and treatment of DM and its complications.

HUMAN GENE THERAPY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

The p53 pathway in vasculature revisited: A therapeutic target for pathological vascular remodeling?

Xiaopei Cui et al.

Summary: Pathological vascular remodeling plays a critical role in various vascular diseases, and activation of p53 may help counteract vascular remodeling and reduce inflammation. Currently, targeting the p53 pathway through pharmacological interventions could be a novel strategy to prevent the development of vascular remodeling.

PHARMACOLOGICAL RESEARCH (2021)

添加到收藏夹

Article Medicine, General & Internal

Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials

Birgit Sawitzki et al.

LANCET (2020)

添加到收藏夹

Review Immunology

The Many Functions of Foxp3+ Regulatory T Cells in the Intestine

Catalina Cosovanu et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

The Role of PTEN in Innate and Adaptive Immunity

Henry Taylor et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)

添加到收藏夹

Article Cell Biology

Inhibition of nucleolar stress response by Sirt1: A potential mechanism of acetylation-independent regulation of p53 accumulation

Xiaolei Bi et al.

AGING CELL (2019)

添加到收藏夹

Article Hematology

Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice

Anusara Daenthanasanmak et al.

BLOOD (2019)

添加到收藏夹

Review Respiratory System

Regulatory T Cells in Respiratory Health and Diseases

Rani Singh et al.

PULMONARY MEDICINE (2019)

添加到收藏夹

Review Critical Care Medicine

Acute Cellular Rejection: Is It Still Relevant?

Angela Koutsokera et al.

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

添加到收藏夹

Article Immunology

The Selective RNA Polymerase I Inhibitor CX-5461 Mitigates Neointimal Remodeling in a Modified Model of Rat Aortic Transplantation

Chaochao Dai et al.

TRANSPLANTATION (2018)

添加到收藏夹

Article Transplantation

Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation

Chetan Naik et al.

TRANSPLANTATION DIRECT (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Transcriptional regulation and development of regulatory T cells

Wonyong Lee et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Foxp3 is a key downstream regulator of p53-mediated cellular senescence

J-E Kim et al.

ONCOGENE (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation

Tiffany C. L. Wong et al.

EXPERT OPINION ON EMERGING DRUGS (2017)

添加到收藏夹

Article Allergy

Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells

Hannah H. Chen et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

添加到收藏夹

Review Immunology

Adipose-tissue regulatory T cells: Critical players in adipose-immune crosstalk

Maike Becker et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2017)

添加到收藏夹

Article Immunology

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Jason D. Fontenot et al.

JOURNAL OF IMMUNOLOGY (2017)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Regulatory T cells in cardiovascular diseases

Xiao Meng et al.

NATURE REVIEWS CARDIOLOGY (2016)

添加到收藏夹

Article Medical Laboratory Technology

Immune mechanisms of acute and chronic rejection

Luis Eduardo Becker et al.

CLINICAL BIOCHEMISTRY (2016)

添加到收藏夹

Article Dermatology

Ultraviolet irradiation promotes FOXP3 transcription via p53 in psoriasis

Dongmei Zhang et al.

EXPERIMENTAL DERMATOLOGY (2016)

添加到收藏夹

Article Immunology

An essential role for the IL-2 receptor in Treg cell function

Takatoshi Chinen et al.

NATURE IMMUNOLOGY (2016)

添加到收藏夹

Review Immunology

Impact of Immune-Modulatory Drugs on Regulatory T Cell

Akiko Furukawa et al.

TRANSPLANTATION (2016)

添加到收藏夹

Article Oncology

Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling

Jaclyn Quin et al.

ONCOTARGET (2016)

添加到收藏夹

Article Multidisciplinary Sciences

PTEN ameliorates autoimmune arthritis through down-regulating STAT3 activation with reciprocal balance of Th17 and Tregs

Seung Hoon Lee et al.

SCIENTIFIC REPORTS (2016)

添加到收藏夹

Article Immunology

Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses

Sharad Shrestha et al.

NATURE IMMUNOLOGY (2015)

添加到收藏夹

Article Immunology

Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability

Alexandria Huynh et al.

NATURE IMMUNOLOGY (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation

M. Girardot et al.

ONCOGENE (2015)

添加到收藏夹

Article Immunology

Role of p53 in Systemic Autoimmune Diseases

Hiroaki Takatori et al.

CRITICAL REVIEWS IN IMMUNOLOGY (2014)

添加到收藏夹

Article Rheumatology

p53 Controls Autoimmune Arthritis via STAT-Mediated Regulation of the Th17 Cell/Treg Cell Balance in Mice

Jin-Sil Park et al.

ARTHRITIS AND RHEUMATISM (2013)

添加到收藏夹

Article Immunology

Tumor Suppressor p53 Inhibits Systemic Autoimmune Diseases by Inducing Regulatory T Cells

Hirotoshi Kawashima et al.

JOURNAL OF IMMUNOLOGY (2013)

添加到收藏夹

Article Medicine, Research & Experimental

Effector Mechanisms of Rejection

Aurelie Moreau et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)

添加到收藏夹

Review Immunology

Generation and function of nducec regulatory T cells

Erica G. Schmitt et al.

FRONTIERS IN IMMUNOLOGY (2013)

添加到收藏夹

Review Immunology

Induced CD4+Foxp3+ Regulatory T Cells in Immune Tolerance

Angelina M. Bilate et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)

添加到收藏夹

Review Immunology

Regulatory T Cells: Mechanisms of Differentiation and Function

Steven Z. Josefowicz et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)

添加到收藏夹

Article Medicine, Research & Experimental

A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53

Qi Zhang et al.

EMBO MOLECULAR MEDICINE (2012)

添加到收藏夹

Review Immunology

Regulatory T cells in the central nervous system

Daniel E. Lowther et al.

IMMUNOLOGICAL REVIEWS (2012)

添加到收藏夹

Article Chemistry, Medicinal

Discovery of CX-5461, the First Direct and Selective Inhibitor of RNA Polymerase I, for Cancer Therapeutics

Mustapha Haddach et al.

ACS MEDICINAL CHEMISTRY LETTERS (2012)

添加到收藏夹

Article Biochemistry & Molecular Biology

Sirtuin-1 Targeting Promotes Foxp3+ T-Regulatory Cell Function and Prolongs Allograft Survival

Ulf H. Beier et al.

MOLECULAR AND CELLULAR BIOLOGY (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

Foxp3 Expression in p53-dependent DNA Damage Responses

Da-Jung Jung et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

添加到收藏夹

Article Immunology

CD4(+)CD25(+) Regulatory T Cells Resist a Novel Form of CD28-and Fas-Dependent p53-Induced T Cell Apoptosis

Nagendra Singh et al.

JOURNAL OF IMMUNOLOGY (2010)

添加到收藏夹

Review Urology & Nephrology

T-cell alloimmunity and chronic allograft dysfunction

Niloufar Safinia et al.

KIDNEY INTERNATIONAL (2010)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Nucleolus under Stress

Severine Boulon et al.

MOLECULAR CELL (2010)

添加到收藏夹

Article Immunology

Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells

Weiming Ouyang et al.

NATURE IMMUNOLOGY (2010)

添加到收藏夹

Article Immunology

The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment

Greg M. Delgoffe et al.

IMMUNITY (2009)

添加到收藏夹

Article Oncology

Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator

Sonia Lain et al.

CANCER CELL (2008)

添加到收藏夹

Review Biochemistry & Molecular Biology

Regulatory T cells and immune tolerance

Shimon Sakaguchi et al.

CELL (2008)

添加到收藏夹

Review Immunology

Regulation of T-cell responses by PTEN

Jodi L. Buckler et al.

IMMUNOLOGICAL REVIEWS (2008)

添加到收藏夹

Article Immunology

STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells

Laura Passerini et al.

INTERNATIONAL IMMUNOLOGY (2008)

添加到收藏夹

Article Immunology

The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells

Sokol Haxhinasto et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2008)

添加到收藏夹

Review Immunology

How regulatory T cells work

Dario A. A. Vignali et al.

NATURE REVIEWS IMMUNOLOGY (2008)

添加到收藏夹

Article Biochemistry & Molecular Biology

Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage

JM Solomon et al.

MOLECULAR AND CELLULAR BIOLOGY (2006)

添加到收藏夹

Article Multidisciplinary Sciences

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

LT Vassilev et al.

SCIENCE (2004)

添加到收藏夹

Review Surgery

T-cell allorecognition and transplant rejection: A summary and update

PS Heeger

AMERICAN JOURNAL OF TRANSPLANTATION (2003)

添加到收藏夹

Article Immunology

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

JD Fontenot et al.

NATURE IMMUNOLOGY (2003)

添加到收藏夹

Article Multidisciplinary Sciences

Control of regulatory T cell development by the transcription factor Foxp3

S Hori et al.

SCIENCE (2003)

添加到收藏夹

Article Biochemistry & Molecular Biology

Regulation of PTEN transcription by p53

V Stambolic et al.

MOLECULAR CELL (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.